Results 191 to 200 of about 102,055 (301)

The Evolution of Autoimmune Gastritis Research (1995-2025): A Hybrid Bibliometric-Conceptual Synthesis. [PDF]

Korean J Helicobacter Up Gastrointest Res
Ahn YH.
europepmc   +1 more source

Emphysematous gastritis

Oxford Medical Case Reports, 2020
Masayuki Shibata, Akihiko Tsuchiya, Ko Nishikawa   +2 more
openaire   +2 more sources

Gastric Microbiota from Populations with High Risk of Gastric Cancer in Nariño, Colombia. [PDF]

Int J Mol Sci
Portilla S, Pazos A, Pabón V, Guzmán KA.   +3 more
europepmc   +1 more source

Comprehensive and reproducible grading of the Updated Sydney System in gastric biopsies using artificial intelligence: multi‐pathologist validation and a reader study

Histopathology, Volume 89, Issue 6, Page 1042-1055, December 2026.
SydneyMTL is an interpretable multi‐task model providing four‐level grading for the five Sydney System attributes. By significantly improving diagnostic concordance and reducing reading time, it offers a robust clinical tool to alleviate pathologist workloads and standardize routine gastric biopsy screening.
Ho Heon Kim, Won Chan Jeong, Yuri Hwang, Gisu Hwang, Kyungeun Kim, Young Sin Ko   +5 more
wiley   +1 more source

Pediatric Eosinophil-Predominant Collagenous Gastritis: From Conventional Therapy to Dupilumab: A Case Report. [PDF]

Reports (MDPI)
Rogalidou M, Patereli A, Stefanaki K, Dimakou K, Stasinou E, Karagianni VM, Margoni D, Papadopoulou A.   +7 more
europepmc   +1 more source

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

Arthritis Care &Research, Volume 78, Issue 11, Page 1618-1630, November 2026.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel, Fauzia Hollangel, Caroline Packee, Amita Kapoor, Brad Rovin, Nathalie Costedoat‐Chalumeau, Shivani Garg   +6 more
wiley   +1 more source

Gastric Mucosa Cancer Risk: The Operative Link on Gastritis Assessment Staging System. [PDF]

Korean J Helicobacter Up Gastrointest Res
Rugge M, Sbaraglia M, Fiorini G, Faa G, Genta RM.   +4 more
europepmc   +1 more source

Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild‐to‐moderate asthma

British Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3819-3830, November 2026.
Abstract Aim Tezepelumab is a human monoclonal antibody that blocks the activity of thymic stromal lymphopoietin and is approved for adolescents and adults with severe asthma. This analysis assessed pharmacokinetics (PK), pharmacodynamics and safety of tezepelumab up to 85 days postdose in adolescents and children.
Anna Lundahl, Jonathan Grigg, Lubna Abuqayyas, Piotr Kuna, Gillian Hunter, Beata Pawlikowska, Jacob Leander, Michael Levin, Atul Gupta, James Paton, Katharine C. Pike, Jane R. Parnes, Gun Almqvist, Stephanie L. Roseti, on behalf of the study investigators   +14 more
wiley   +1 more source

Reply: Comments by Professor Xiaoran Sun on "Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study". [PDF]

J Gastric Cancer
Ohashi T, Kubota T.
europepmc   +1 more source

Plasma IFNL3 for Gastric Cancer Detection and Monitoring in East Asians: A Multiphase Study

Cancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Gastric cancer (GC) has a high incidence in East Asia, yet early detection remains limited. Methods In this multiphase study, 395 participants (96 GC, 72 precancerous lesions, 227 healthy donors) were enrolled. Plasma IFNL3 levels were measured using ELISA.
Yunmeng Nie, Jihong Zhong, Siyi Ni, Yingchao Liu, Shuo Zhang, Guangji Zhang   +5 more
wiley   +1 more source